Effect of polyethyleneglycol on coenzyme Q10 bioavailability from nanosystems in vitro

被引:1
|
作者
Karlina, M. V. [1 ]
Kosman, V. M. [1 ]
Pozharitskaya, O. N. [1 ]
Shikov, A. N. [1 ]
Makarov, V. G. [1 ]
Heinamaki, J. [2 ]
Yliruusi, J. [2 ]
Hiltunen, R. [2 ]
机构
[1] St Petersburg Inst Pharm, St Petersburg 195067, Russia
[2] Univ Helsinki, Fac Pharm, FI-00014 Helsinki, Finland
关键词
coenzyme Q10; nanosystem; bioavailability; Q(10); DISSOLUTION;
D O I
10.1007/s11094-012-0770-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Coenzyme Q10 (CoQ10) is a natural antioxidant of the oil-soluble benzoquinone group that is involved in electron transport in mitochondria. CoQ10 possesses a broad spectrum of pharmacological activity. However, its insolubility in water and low bioavailability upon peroral administration are significant disadvantages. The present work was aimed at a biopharmaceutical evaluation of nanosystems (NS) with CoQ10 that are suitable for peroral administration and exhibit increased bioavailability in vitro. Solid NS of CoQ10 with polyethyleneglycol (PEG) carriers of various molecular weights (1,500; 6,000; 35,000) were prepared in order to increase the dissolution rate of CoQ10. The NS particle sizes were in the range 48.4 - 200.3 nm. The influences of the PEG molecular weight and the ratio of NS components were evaluated using dispersion analysis. Regression equations describing the effects of these factors on the drug-release and dissolution rates were obtained by processing the results. Response surfaces that adequately described drug dissolution were plotted.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 50 条
  • [21] Coenzyme Q10
    Vormann, J
    AGRO FOOD INDUSTRY HI-TECH, 2004, 15 (03): : 34 - 37
  • [22] Coenzyme Q10
    不详
    ALTERNATIVE MEDICINE REVIEW, 2007, 12 (02) : 159 - 168
  • [23] Coenzyme Q10
    Bonakdar, RA
    Guarneri, E
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (06) : 1065 - 1070
  • [24] Coenzyme Q10
    Pepping, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (06) : 519 - 521
  • [25] Coenzyme Q10
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1229): : 19 - 20
  • [26] Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency
    Montini, Giovanni
    Malaventura, Cristina
    Salviati, Leonardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26): : 2849 - 2850
  • [27] Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients
    Kuriyama, Naohide
    Nakamura, Tomoyuki
    Nakazawa, Harumasa
    Wen, Tyler
    Berra, Lorenzo
    Bittner, Edward A.
    Goverman, Jeremy
    Kaneki, Masao
    METABOLITES, 2022, 12 (07)
  • [28] PEGylation of coenzyme Q10 and in vitro release studies
    Zacchigna, M.
    Cateni, F.
    Procida, G.
    Zampieri, D.
    Mamolo, M. G.
    PHARMAZIE, 2017, 72 (12): : 714 - 720
  • [29] In vitro bioaccessibility of coenzyme Q10 in enriched yoghurts
    Ercan, Pinar
    El Sedef, Nehir
    INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, 2012, 47 (09): : 1986 - 1992
  • [30] Plasma Coenzyme Q10 and Tocopherols in Thoroughbred Race Horses: Effect of Coenzyme Q10 Supplementation and Exercise
    Sinatra, Stephen T.
    Jankowitz, Stanley N.
    Chopra, Raj K.
    Bhagavan, Hemmi N.
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2014, 34 (02) : 265 - 269